Doctors Note Logo

Published on: 9/15/2026

How do I know if my rash on lamotrigine is serious?

Most rashes on lamotrigine are mild, but any new rash in the first 2 to 8 weeks of starting or increasing the dose should be treated as potentially serious until a clinician says otherwise. Warning signs of a severe reaction like Stevens-Johnson syndrome or DRESS include fever, sore throat, facial or eyelid swelling, swollen glands, painful or blistering skin, peeling, or sores in the mouth, eyes, or genitals, and these warrant emergency care. Risk is higher with rapid dose escalation, use alongside valproate, a prior rash with another anti-seizure medication, and in children. Do not stop the medication abruptly on your own if you take it for seizures, but do contact your prescriber the same day a rash appears. There are several factors that determine urgency, including timing, spread, and accompanying symptoms, so see below to understand more before deciding what to do next.

Because rashes can look alike while carrying very different risks, a structured check of your specific symptoms is a smart first step. A free, instant, online symptom check can help you organize what you are experiencing, gauge how urgent it may be, and prepare clear information for your prescriber or an emergency visit.

Last reviewed for medical accuracy: 09/15/2026

answer background

Explanation

How Do I Know If My Rash on Lamotrigine Is Serious?

Lamotrigine is an anticonvulsant medication used to treat epilepsy and bipolar disorder. One of its well-known side effects is rash. Most rashes from lamotrigine are mild and go away on their own, but some can signal a serious reaction. This guide helps you recognize the warning signs, take appropriate steps, and know when to seek medical help.

Why Rashes Happen with Lamotrigine

  • Lamotrigine can trigger an immune response in your skin.
  • About 7–10% of people taking lamotrigine develop a rash.
  • Serious rashes (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis) are rare but potentially life-threatening.
  • Risk is highest during the first 2 to 8 weeks of treatment, especially if doses are increased too quickly.

Mild vs. Serious Rashes

Mild Rashes

  • Small, flat, or slightly raised red spots
  • Itchy but limited in size (often under 5 cm across)
  • No blistering or peeling
  • No fever or other symptoms

What to do:

  • Call your doctor if the rash is bothersome.
  • You may continue lamotrigine under medical guidance.
  • Over-the-counter antihistamines or soothing creams can help.

Warning Signs of a Serious Rash

Serious skin reactions can progress rapidly. Look for any of these red flags:

  • Widespread rash covering large body areas
  • Target-shaped lesions (bull’s-eye or “iris” pattern)
  • Blistering or peeling skin
  • Mucosal involvement—sores or ulcers in mouth, eyes, genitals
  • Fever or flu-like symptoms
  • Swollen lymph nodes
  • Facial swelling
  • Muscle or joint pain
  • Rapid progression—rash gets worse day by day

If you notice one or more of these signs, treat the rash as potentially serious.

What to Do If You Suspect a Serious Rash

  1. Stop Lamotrigine Immediately
    Any sign of a serious rash warrants stopping the medication. Do not restart without medical approval.

  2. Seek Prompt Medical Attention

    • Go to your nearest emergency department if you have blisters, peeling, or fever.
    • Call your doctor right away if you have early warning signs (large rash, spreading redness, target lesions).
  3. Symptom Check
    If you’re unsure how urgent your symptoms are, consider a
    free, online symptom check, using the doctor approved Ubie Symptom Checker.
    This tool can help you decide if you need to head to the ER or call your healthcare provider.

  4. Document Your Symptoms

    • Take clear photos of the rash each day.
    • Note when the rash started, how it has changed, and any other symptoms (fever, sore throat, fatigue).
  5. Emergency Treatments
    In the hospital, you may receive:

    • Intravenous fluids and nutrition
    • Pain control and wound care
    • High-dose steroids or immunoglobulins (in some cases)
    • Management in a burn unit or intensive care if the reaction is very severe

Reducing Your Risk of Rash

  • Follow a Slow Dose-Escalation Schedule
    Lamotrigine is started at a low dose (e.g., 25 mg daily) and increased slowly over weeks.
  • Avoid Rapid Dose Increases
    Doubling your dose too quickly raises the rash risk.
  • Watch for Drug Interactions
    Valproate, for example, can increase lamotrigine levels and rash risk. Always tell your doctor about all medications and supplements you take.
  • Stay Alert During the First 2 Months
    Most serious rashes appear within 6 to 8 weeks of starting or increasing lamotrigine.

Frequently Asked Questions

Q: Can I restart lamotrigine after a mild rash?
A: Sometimes. If your doctor determines the rash was mild and not an immune-mediated reaction, they may reintroduce lamotrigine at a very low dose with slow escalation and close monitoring.

Q: Is itching always a sign of a serious problem?
A: No. Mild itching can accompany harmless rashes. Watch for other warning signs (see “Warning Signs of a Serious Rash”). If itching persists or worsens, contact your doctor.

Q: How long does a mild rash last?
A: Typically 1 to 2 weeks after stopping lamotrigine or after the rash begins. If it lingers longer, check back in with your healthcare provider.

Q: Are there genetic tests to predict rash risk?
A: Currently, no widely used genetic test accurately predicts lamotrigine-related rash in most populations.

When to Talk to Your Doctor

Even if your rash seems mild, keep your doctor in the loop. You should always reach out if you experience:

  • Any new rash after starting lamotrigine
  • Fever, sore throat, or swollen glands
  • Rash that spreads or changes rapidly
  • Blistering, peeling, or mucosal sores

If you experience signs that could be life-threatening—such as blistering skin, widespread redness, fever, or difficulty breathing—seek emergency care immediately.

Final Thoughts

Rashes from lamotrigine range from mild irritation to rare but serious reactions like Stevens-Johnson syndrome. Knowing the difference—and acting fast—can make all the difference in your safety and treatment success.

Always:

Your vigilance, combined with proper medical guidance, helps ensure you get the benefits of lamotrigine while minimizing risks. Stay informed, stay safe, and don’t hesitate to seek help when you need it.

(References)

  • * Burstein AH. Lamotrigine. Pharmacotherapy. 1995 Mar-Apr;15(2):129-43. PMID: 7624259.

  • * Messenheimer JA. Lamotrigine. Epilepsia. 1995;36 Suppl 2:S87-94. doi: 10.1111/j.1528-1157.1995.tb06002.x. PMID: 8784217.

  • * Matsuo F. Lamotrigine. Epilepsia. 1999;40 Suppl 5:S30-6. doi: 10.1111/j.1528-1157.1999.tb00917.x. PMID: 10530692.

  • * Sarzi-Puttini P, Panni B, Cazzola M, Muzzupappa S, Turiel M. Lamotrigine-induced lupus. Lupus. 2000;9(7):555-7. doi: 10.1177/096120330000900715. PMID: 11035425.

  • * Hilas O, Charneski L. Lamotrigine-induced Stevens-Johnson syndrome. Am J Health Syst Pharm. 2007 Feb 1;64(3):273-5. doi: 10.2146/ajhp060071. PMID: 17244876.

  • * Reed KL, Quinn KB, Gust AJ. Lamotrigine-induced cutaneous pseudolymphoma. Cutis. 2019 Aug;104(2):E1-E3. PMID: 31603965.

  • * Velázquez-Cárcamo EA, Rodríguez-Chávez Y, Méndez-Flores S, Domínguez-Cherit J. [Lamotrigine and its relationship with Stevens-Johnson syndrome and toxic epidermal necrolysis]. Rev Med Inst Mex Seguro Soc. 2020 Apr 13;58(2):202-205. doi: 10.24875/RMIMSS.M20000018. Epub 2020 Apr 13. PMID: 34101565.

  • * Meledathu S, Gordon M, Thornton M, Ashinoff R. Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review. J Drugs Dermatol. 2023 Nov 1;22(11):e24-e28. doi: 10.36849/JDD.6999. PMID: 37943271.

  • * Zhou L, Lu Y, Zou Y, Wei H, Guo X, Li Q, Zhou Y, Zhao X, Xie F, Zhang L. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year retrospective study of 103 cases. Clin Exp Dermatol. 2025 Oct 27;50(11):2200-2208. doi: 10.1093/ced/llaf278. PMID: 40579172.

  • * Bayram-Ozgur D, Colak O, Gultekin O, Akici N, Onal ZE, Akici A. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: age-stratified insights from the FAERS database. J Pediatr (Rio J). 2025 Nov-Dec;101(6):101455. doi: 10.1016/j.jped.2025.101455. Epub 2025 Oct 23. PMID: 41075813; PMCID: PMC12593532.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.